Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

memo - Magazine of European Medical Oncology

Issue 2/2021

Content (20 Articles)

Solid Tumor editorial

Immunotherapy revisited

Thorsten Füreder

Malnutrition editorial

Treatment approaches towards physical activity – malnutrition – cognitive impairment

Marlene Troch

NSCLC editorial

European Society for Medical Oncology 2020

Rupert Bartsch

editorial

Neuro-oncology 2021

Silvia Hofer

editorial

memo—publisher’s report 2020

Alois Sillaber

Open Access Melanoma short review

Novel immune checkpoints beyond PD-1 in advanced melanoma

Nina Zila, Christoph Hoeller, Verena Paulitschke

Glioblastoma review

CAR T cell therapy in solid tumors: a short review

Öykü Umut, Adrian Gottschlich, Stefan Endres, Sebastian Kobold

NSCLC short review

DNA methylation as predictive marker of response to immunotherapy?

Gerwin Heller

Open Access Exercise Therapy review

Importance of performance status and physical activity in cancer patients

David Kiesl

Cytostatic Therapy review

Cognitive impairment in cancer patients and survivors—clinical presentation, pathophysiology, diagnosis and management

Markus Hutterer, Stefan Oberndorfer

Sarcopenia short review

Malnutrition and cancer, diagnosis and treatment

Angelika Beirer

NSCLC short review

ESMO virtual congress 2020—highlights NSCLC

Barbara Kiesewetter

Targeted Therapy short review

ESMO 2020 update: Pancreatic cancer

Elisabeth Sophie Bergen

Esophageal Cancer original report

Update ESMO: gastric and esophageal cancer

Ulrich Popper, Holger Rumpold

Breast Cancer short review

ESMO 2020: highlights in breast cancer

Rupert Bartsch

Ependymoma short review

WHO classification of tumors of the nervous system: preview of the upcoming 5th edition

Elisabeth J. Rushing

Metastasis short review

Leptomeningeal metastases from solid tumours

Silvia Hofer, Emilie Le Rhun

Open Access NSCLC short review

Brain metastases: new systemic treatment approaches

Ariane Steindl, Anna Sophie Berghoff

Metastasis short review

Are there still indications for whole brain irradiation in 2021?

Karin Dieckmann, Harald Herrmann

Gastrointestinal Stromal Tumor case report

Unique gastrointestinal stromal tumor with PDGFRA D842Y mutation—evaluation of in vivo sensitivity to imatinib

Olga Kuczkiewicz-Siemion, Agnieszka Dansonka-Mieszkowska, Piotr Rutkowski, Anna Klimczak, Andrzej Tysarowski, Monika Prochorec-Sobieszek, Anna Szumera-Ciećkiewicz

Apr 21
Issue: Special Issue 3/2021
Report from the WCLC 2020 virtual Congress, January 28th–31th,
Sep 21
Issue: 3/2021

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits